Cerus Corp financial data

Symbol
CERS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1220 Concord Avenue, Suite 600, Concord, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 209 % +16.4%
Quick Ratio 58.2 % +76.5%
Debt-to-equity 292 % +38.5%
Return On Equity -61.8 % +6.56%
Return On Assets -16 % +25.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 185 M shares +2.4%
Common Stock, Shares, Outstanding 181 M shares +2.06%
Entity Public Float 373 M USD -58.8%
Common Stock, Value, Issued 185 K USD +2.78%
Weighted Average Number of Shares Outstanding, Basic 182 M shares +2.14%
Weighted Average Number of Shares Outstanding, Diluted 182 M shares +2.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 187 M USD -0.81%
Operating Income (Loss) -23.9 M USD +37.8%
Nonoperating Income (Expense) -7.49 M USD -2.38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.4 M USD +31.3%
Income Tax Expense (Benefit) 322 K USD -34.2%
Net Income (Loss) Attributable to Parent -31.6 M USD +31.6%
Earnings Per Share, Basic -0.17 USD/shares +34.6%
Earnings Per Share, Diluted -0.17 USD/shares +34.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.5 M USD -25.6%
Accounts Receivable, after Allowance for Credit Loss, Current 22.5 M USD -10.7%
Inventory, Net 39.9 M USD +8.87%
Assets, Current 138 M USD -14.8%
Property, Plant and Equipment, Net 8.1 M USD -25.2%
Operating Lease, Right-of-Use Asset 10.2 M USD -17%
Goodwill 1.32 M USD 0%
Other Assets, Noncurrent 11.7 M USD -43.9%
Assets 189 M USD -9.65%
Accounts Payable, Current 16.6 M USD -54.4%
Employee-related Liabilities, Current 8.88 M USD -24.9%
Accrued Liabilities, Current 16.2 M USD -16.2%
Contract with Customer, Liability, Current 2.17 M USD +28%
Liabilities, Current 57.2 M USD -26.2%
Operating Lease, Liability, Noncurrent 13.5 M USD -9.97%
Other Liabilities, Noncurrent 3.43 M USD +42.3%
Liabilities 139 M USD -7.21%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.12 M USD +49.9%
Retained Earnings (Accumulated Deficit) -1.05 B USD -3.09%
Stockholders' Equity Attributable to Parent 49.4 M USD -15.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 50.2 M USD -15.8%
Liabilities and Equity 189 M USD -9.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.96 M USD
Net Cash Provided by (Used in) Financing Activities 5.56 M USD +170%
Net Cash Provided by (Used in) Investing Activities 1.45 M USD
Common Stock, Shares Authorized 400 M shares 0%
Common Stock, Shares, Issued 181 M shares +2.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.88 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.2 M USD -24.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9.21 M USD +80.6%
Deferred Tax Assets, Valuation Allowance 217 M USD +0.46%
Deferred Tax Assets, Gross 219 M USD +0.26%
Operating Lease, Liability 15.7 M USD -8.53%
Payments to Acquire Property, Plant, and Equipment 1.1 M USD -27.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.4 M USD +34.8%
Lessee, Operating Lease, Liability, to be Paid 20.1 M USD -11.8%
Property, Plant and Equipment, Gross 25.1 M USD -0.29%
Operating Lease, Liability, Current 2.19 M USD +1.44%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.16 M USD +4.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.31 M USD -1.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.42 M USD -21.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.46 M USD +13.4%
Deferred Tax Assets, Operating Loss Carryforwards 133 M USD -2.31%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 2 K USD
Current Income Tax Expense (Benefit) 321 K USD -38.9%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 7.92 M USD -8.41%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.26 M USD -2.89%
Operating Lease, Payments 968 K USD +3.64%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 36 K USD +620%
Depreciation, Depletion and Amortization 631 K USD -0.63%
Deferred Tax Assets, Net of Valuation Allowance 2.32 M USD -15.5%
Share-based Payment Arrangement, Expense 20.3 M USD -17.1%
Deferred State and Local Income Tax Expense (Benefit) 2 K USD
Interest Expense 9.01 M USD +48.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%